These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20434921)

  • 1. Future of local bone regeneration - Protein versus gene therapy.
    Fischer J; Kolk A; Wolfart S; Pautke C; Warnke PH; Plank C; Smeets R
    J Craniomaxillofac Surg; 2011 Jan; 39(1):54-64. PubMed ID: 20434921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
    Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
    Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-based gene therapy strategies for bone regeneration.
    Phillips JE; Gersbach CA; García AJ
    Biomaterials; 2007 Jan; 28(2):211-29. PubMed ID: 16928397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
    Lee SH; Shin H
    Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporally controlled multiple-gene delivery in scaffolds: A promising strategy to enhance bone regeneration.
    Liu J; Xu L; Li Y; Ma J
    Med Hypotheses; 2011 Feb; 76(2):173-5. PubMed ID: 20926199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone tissue engineering by gene delivery.
    Kofron MD; Laurencin CT
    Adv Drug Deliv Rev; 2006 Jul; 58(4):555-76. PubMed ID: 16790291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic proteins and tissue engineering: future directions.
    Calori GM; Donati D; Di Bella C; Tagliabue L
    Injury; 2009 Dec; 40 Suppl 3():S67-76. PubMed ID: 20082795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward delivery of multiple growth factors in tissue engineering.
    Chen FM; Zhang M; Wu ZF
    Biomaterials; 2010 Aug; 31(24):6279-308. PubMed ID: 20493521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo bone morphogenetic protein-2 gene delivery using gingival fibroblasts promotes bone regeneration in rats.
    Shin JH; Kim KH; Kim SH; Koo KT; Kim TI; Seol YJ; Ku Y; Rhyu IC; Chung CP; Lee YM
    J Clin Periodontol; 2010 Mar; 37(3):305-11. PubMed ID: 20041973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering osteogenesis and chondrogenesis with gene-enhanced therapeutic cells.
    Hao J; Varshney RR; Wang DA
    Curr Opin Mol Ther; 2009 Aug; 11(4):404-10. PubMed ID: 19649985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor delivery for bone tissue repair: an update.
    Varkey M; Gittens SA; Uludag H
    Expert Opin Drug Deliv; 2004 Nov; 1(1):19-36. PubMed ID: 16296718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering.
    Schek RM; Wilke EN; Hollister SJ; Krebsbach PH
    Biomaterials; 2006 Mar; 27(7):1160-6. PubMed ID: 16112727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.
    Issa JP; Bentley MV; Iyomasa MM; Sebald W; De Albuquerque RF
    Anat Histol Embryol; 2008 Jun; 37(3):181-7. PubMed ID: 18070240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7.
    Zhao M; Zhao Z; Koh JT; Jin T; Franceschi RT
    J Cell Biochem; 2005 May; 95(1):1-16. PubMed ID: 15759283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds.
    Kim S; Kim SS; Lee SH; Eun Ahn S; Gwak SJ; Song JH; Kim BS; Chung HM
    Biomaterials; 2008 Mar; 29(8):1043-53. PubMed ID: 18023477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein- and gene-based tissue engineering in bone repair.
    Kofron MD; Li X; Laurencin CT
    Curr Opin Biotechnol; 2004 Oct; 15(5):399-405. PubMed ID: 15464368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated gene therapy for bone formation and regeneration.
    Turgeman G; Aslan H; Gazit Z; Gazit D
    Curr Opin Mol Ther; 2002 Aug; 4(4):390-4. PubMed ID: 12222877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural polymers for gene delivery and tissue engineering.
    Dang JM; Leong KW
    Adv Drug Deliv Rev; 2006 Jul; 58(4):487-99. PubMed ID: 16762443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.